Biotech company TG Therapeutics (TGTX.US) stock price drops significantly, Q1 earnings below expectations.

05/05/2025

The first quarter financial report for 2025 announced by TG Therapeutics shows that the Q1 revenue was 121 million US dollars, a year-on-year growth of 90.4%, higher than analysts' expectations by 3 million US dollars; GAAP earnings per share were $0.03, lower than analysts' expectations by $0.14.

At the beginning of Monday's trading session, shares of biopharmaceutical company TG Therapeutics (TGTX.US) plummeted nearly 15% as of the time of writing. On the news front, TG Therapeutics announced its financial results for the first quarter of 2025, with Q1 revenue reaching $121 million, a year-on-year increase of 90.4%, surpassing analyst expectations by $3 million. GAAP earnings per share were $0.03, falling short of analyst expectations by $0.14.

HK Stock Market Move | CHINAGOLDINTL(02099) rises over 5%, company's first quarter report to be disclosed soon, Jiamak mineral resources have huge storage space.

HK Stock Market Move | Link (00823) rose more than 6% during trading session. REITs are expected to be included in Shanghai-Hong Kong Stock Connect. Link recently launched fund management business.

Guosheng Securities: Siasun Robot & Automation accelerates tendon rope infiltration and focuses on ultra-high molecular weight polyethylene.

HK Stock Market Move | CHINAGOLDINTL(02099) rises over 5%, company's first quarter report to be disclosed soon, Jiamak mineral resources have huge storage space.

HK Stock Market Move | Link (00823) rose more than 6% during trading session. REITs are expected to be included in Shanghai-Hong Kong Stock Connect. Link recently launched fund management business.

Guosheng Securities: Siasun Robot & Automation accelerates tendon rope infiltration and focuses on ultra-high molecular weight polyethylene.